Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ivuxolimab, an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody, targets a costimulatory receptor found on activated CD4+ and CD8+ T cells. It demonstrates antitumor properties and may exhibit immunostimulatory activity [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $215 | 2-4 weeks | |
5 mg | $556 | 2-4 weeks | |
10 mg | $868 | 2-4 weeks |
Description | Ivuxolimab, an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody, targets a costimulatory receptor found on activated CD4+ and CD8+ T cells. It demonstrates antitumor properties and may exhibit immunostimulatory activity [1]. |
Cas No. | 2128729-41-7 |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.